Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study

被引:5
作者
Verheyden, Benny [1 ]
Roumeguere, Thierry [2 ]
Bitton, Alain
Belger, Mark
Schmitt, Henry [3 ]
机构
[1] Univ Antwerp Hosp, Androl Unit, Dept Urol, B-2650 Edegem, Antwerp, Belgium
[2] Free Univ Brussels, Erasme Hosp, B-1050 Brussels, Belgium
[3] Eli Lilly & Co, Brussels, Belgium
关键词
Couple; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitor; Tadalafil; Sexual Relationship; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; MULTINATIONAL MENS ATTITUDES; SILDENAFIL CITRATE TREATMENT; TREATMENT-SATISFACTION; FEMALE PARTNERS; DOUBLE-BLIND; SEXUAL DYSFUNCTION; VARDENAFIL TREATMENT; DEPRESSIVE SYMPTOMS;
D O I
10.1111/j.1743-6109.2009.01527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Erectile dysfunction (ED) is distressing and can affect a couple's relationship. Aim. To investigate partner awareness of ED, relationship problems, and the effects of tadalafil treatment over 12 months. Methods. The Determinants of Continued Use of Tadalafil study is a prospective 12-month European observational study in patients with ED initiating or changing treatment to on-demand tadalafil. A total of 1,900 patients were enrolled in eight countries. Assessments were made on predefined treatment outcomes in a routine clinical setting. Main Outcome Measures. At baseline, 1, 6, and 12 months, patients were asked about relationship problems (unspecified), partner awareness and support of consultation, and partner sexual problems. Data were analyzed for patients continuing tadalafil at 12 months. Results. At baseline, 96% of patients had a partner, 80% of partners supported an ED consult, and 73% were aware of the consultation. Relationship problems were reported by 17% of patients at baseline. At 12 months, 84% of patients were still taking tadalafil. Of these, 19% reported relationship problems at baseline. After 12 months of treatment with tadalafil, 4% of patients still reported perceived problems. Factors associated with no relationship problems at 12 months were: at baseline, no previous ED treatment, partner in poor health; and at 12 months a lower ED severity. If the partner was felt to have a sexual problem at 12 months, relationship improvement was less likely. Further, 3% of patients developed relationship problems during treatment. Factors associated with developing a relationship problem were: a history of pelvic surgery at baseline, a different partner at 12 months than at baseline, and a partner with a sexual problem at 12 months. Conclusions. Improvement of ED with tadalafil was associated with reduced relationship problems, suggesting that problems were associated with ED and resolved with treatment. Verheyden B, Roumeguere T, Bitton A, Belger M, and Schmitt H. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: Results from the DETECT study. J Sex Med 2009;6:3458-3468.
引用
收藏
页码:3458 / 3468
页数:11
相关论文
共 58 条
[21]   The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction [J].
Fisher, William A. ;
Rosen, Raymond C. ;
Eardley, Ian ;
Niederberger, Craig ;
Nadel, Andrea ;
Kaufman, Joel ;
Sand, Michael .
JOURNAL OF SEXUAL MEDICINE, 2004, 1 (02) :150-160
[22]   On life satisfaction in male erectile dysfunction [J].
FuglMeyer, AR ;
Lodnert, G ;
Branholm, IB ;
FuglMeyer, KS .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1997, 9 (03) :141-148
[23]   Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial [J].
Goldstein, I ;
Fisher, WA ;
Sand, M ;
Rosen, RC ;
Mollen, M ;
Brock, G ;
Karlin, G ;
Pommerville, P ;
Bangerter, K ;
Bandel, TJ ;
Derogatis, LR .
JOURNAL OF SEXUAL MEDICINE, 2005, 2 (06) :819-832
[24]   Worry, Desire, and Sexual Satisfaction and Their Association with Severity of ED and Age [J].
Gralla, Oliver ;
Knoll, Nina ;
Fenske, Stephan ;
Spivak, Inna ;
Hoffmann, Marga ;
Roennebeck, Claudia ;
Lenk, Severin ;
Hoschke, Bernd ;
May, Matthias .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 (11) :2646-2655
[25]   Sexual dysfunction in women partners of men with erectile dysfunction [J].
Greenstein, A ;
Abramov, L ;
Matzkin, H ;
Chen, J .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (01) :44-46
[26]   Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra®) for erectile dysfunction:: a multicentre, randomised, double-blind, placebo-controlled trial [J].
Heiman, J. R. ;
Talley, D. R. ;
Bailen, J. L. ;
Oskin, T. A. ;
Rosenberg, S. J. ;
Pace, C. R. ;
Creanga, D. L. ;
Bavendam, T. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (04) :437-447
[27]   The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction [J].
Ichikawa, T ;
Takao, A ;
Manabe, D ;
Saegusa, M ;
Tanimoto, R ;
Aramaki, K ;
Yamamoto, M ;
Okazaki, T .
INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (09) :755-762
[28]   Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra®)? [J].
Klotz, T ;
Mathers, M ;
Klotz, R ;
Sommer, F .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (01) :2-4
[29]   Epidemiology of erectile dysfuinction [J].
Kubin, M ;
Wagner, G ;
Fugl-Meyer, AR .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (01) :63-71
[30]   Sexual dysfunction in the United States - Prevalence and predictors [J].
Laumann, EO ;
Paik, A ;
Rosen, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06) :537-544